Peptide Storage: Why Reconstituted Vial Timelines Can't Be Verified

"How long does a reconstituted peptide last?" is one of the most searched questions in the peptide world, and the answers online are oddly precise: so many days in the fridge, so many weeks in the freezer. Almost none of those numbers come from stability testing. This page explains where real storage instructions come from, why they exist for approved medicines, and why nobody can give a verified answer for research peptides.

Why do peptides degrade at all?

Peptides are short chains of amino acids, and they are fragile compared with most tablet medicines. Pharmaceutical scientists group the problems into two families, summarised in a widely cited 2010 review of protein drug stability in Pharmaceutical Research:

• Chemical instability: the molecule itself changes, for example by reacting with oxygen or water, so it may lose activity or become a different compound.
• Physical instability: molecules clump together (aggregation) or stick to surfaces, without the chemistry necessarily changing.

Aggregation is not just a potency issue. The FDA, reviewing peptides proposed for compounding, repeatedly flags that aggregation and peptide-related impurities may cause immunogenicity, meaning the body mounts an immune response against the product. You cannot see these changes by looking at a vial.

"Reconstituted" simply means a freeze-dried powder that has been mixed with liquid. Once that happens, the peptide is in solution, where most degradation reactions happen more readily than in the dry state, and every puncture of the stopper is a chance for contamination.

How do approved medicines answer the storage question?

With data. Before a peptide medicine is approved, the manufacturer must show how long it stays within specification under defined conditions, and the regulator turns that into label wording. The EU product information for two semaglutide medicines shows what that looks like:

• Wegovy: store in a refrigerator at 2°C to 8°C, keep away from the cooling element, do not freeze, and protect from light. Single-dose pens may be kept unrefrigerated for up to 28 days at no more than 30°C, then discarded.
• Ozempic: unopened pens have a three-year shelf life in the fridge. After first use, the in-use period is six or eight weeks depending on the pen, stored below 30°C or in the fridge.

Notice how specific those statements are: they differ by product and even by pen type. That is the point. Storage limits are a property of a particular formulation, tested in a particular container, not a general rule for "peptides". You cannot borrow Ozempic's numbers for anything else.

Approved medicine vs research peptide: what is different?

Why is there no reliable storage answer for research peptides?

Because the starting point is unknown. Storage advice assumes you know what is in the vial and that it was sterile to begin with. Independent testing suggests neither can be assumed:

• In a 2024 test-purchase study in the Journal of Medical Internet Research, researchers bought semaglutide from illegal online sellers. Only three vials arrived; the pens ordered were never delivered. All three vials contained endotoxin (a bacterial toxin that can cause fever and inflammation), and measured purity was 7.7% to 14.4% against the 99% claimed on the labels. The sample is small, but every product tested failed.
• The Alcohol and Drug Foundation reports that testing of products sold as retatrutide found peptide content from around half to almost double the labelled amount.
• Reporting on the TGA's April 2026 warning, newsGP noted the regulator's point that there is no reliable assurance about vial contents, dose accuracy or sterility for unapproved peptides.

Refrigeration slows degradation. It does not remove endotoxin, sterilise a contaminated solution or correct a mislabelled dose. A perfectly stored vial of the wrong thing is still the wrong thing.

What about the "28-day rule" for opened vials?

The FDA does give a general figure, but for a different situation. For multi-dose vials of sterile medicines dispensed by pharmacies, it recommends use within 28 days after first use because contamination risk rises after that, and advises not using any injectable GLP-1 medicine that arrives warm. That is a ceiling for a product that started sterile and was made by a regulated pharmacy. It is not evidence that a research peptide is stable or safe for 28 days, or for any period at all.

Are research peptides legal to use in Australia?

NSW Health states that it is unlawful to import, advertise, manufacture and supply unapproved peptide products in Australia. Its advice is plain: if a peptide was not prescribed or recommended by your usual healthcare professional and supplied through a registered Australian pharmacy, do not buy or use it. NSW Health also reports more emergency department presentations after unapproved peptide use, including vomiting that is hard to control, severe allergic reactions and infections.

How do you get storage right for a prescribed peptide medicine?

1. Read the Consumer Medicine Information leaflet that comes with the medicine; it has a storage section written for patients.
2. Check the carton and label for the expiry date and any in-use period after first opening.
3. Ask your pharmacist about anything unclear, including travel, heat and what to do if the medicine was left out.
4. Do not guess after a mistake. If a pen froze or sat in a hot car, call the pharmacist before using it.
5. Return unused or expired medicine to a pharmacy for disposal rather than keeping it "just in case".

If you are reading about specific peptides, the evidence and regulation explainers on retatrutide vs semaglutide, Semax and GHK-Cu apply the same test: what has actually been verified, and by whom.